搜尋
Canopy Growth Corp
CGC添加自選
0.946USD
0.0000.00%
收盤 06/26, 16:00（美東）報價延遲15分鐘
399.23M總市值
虧損本益比TTM
關鍵數據
--今開
0.000最高
0.00成交量
虧損本益比TTM
虧損本益比動
--股利TTM
1.20%換手率
0.946昨收
0.000最低
0.00成交額
虧損本益比靜
0.80市淨率
0.00%股息率 TTM
-28.83%ROA
3.28052週最高
1.40量比
-598.12M淨利潤
422.07M總股本
-1.3551每股盈餘TTM
2.42Beta
-48.50%ROE
1.18052週最低
3.93%振幅
11.60%毛利率
399.23M總市值
-3.03回報/風險
5.36%風險率
TradingKey Canopy Growth Corp股票評分
單位: USD 更新時間: 2026-06-26操作建議
Canopy Growth Corp當前公司基本面數據相對健康，增長潛力很大。當前估值合理，在藥品行業排名107/157位。機構持股佔比非常高，近一月多位分析師給出公司評級為持有。最高目標價為1.22。中期看，股價處於平穩狀態。近一個月，市場表現較差，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Canopy Growth Corp評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看空
Canopy Growth Corp亮點
亮點風險
Canopy Growth Corporation is a Canada-based cannabis company. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
估值合理
公司最新PE估值-0.70，處於3年歷史合理位
機構加倉
最新機構持股46.90M股，環比增加9.85%
活躍度降低
近期活躍度降低，過去20天平均換手率-0.56
分析師目標
基於
3
分析師
持有
評級
1.220
目標均價
+33.61%
漲幅空間
數據免責聲明：分析師評級與目標價由LSEG提供，僅供參考，不應當作投資建議
Canopy Growth Corp新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Canopy Growth Corp簡介
Canopy Growth Corporation is a Canada-based cannabis company. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
公司代碼CGC
公司Canopy Growth Corp
CEOMongeau (Luc)
網址https://www.canopygrowth.com/
相關品種
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%熱門品種
51752.200
-272.500 (-0.52%)
28987.500
-467.500 (-1.59%)
7332.000
-34.800 (-0.47%)
15282.000
-469.000 (-2.98%)
69508.000
-1624.000 (-2.28%)
6207.100
-58.700 (-0.94%)
70.148
-1.196 (-1.68%)
283.780
0.000 (0.00%)
192.530
0.000 (0.00%)
4087.760
+61.610 (+1.53%)
常見問題
Canopy Growth Corp(CGC)的當前股價是多少？
Canopy Growth Corp(CGC)的當前股價是 0.95。
Canopy Growth Corp 的股票代碼是什麼？
Canopy Growth Corp的股票代碼是CGC。
Canopy Growth Corp股票的52週最高點是多少？
Canopy Growth Corp股票的52週最高點是3.28。
Canopy Growth Corp股票的52週最低點是多少？
Canopy Growth Corp股票的52週最低點是1.18。
Canopy Growth Corp的市值是多少？
Canopy Growth Corp的市值是417.01M。
現在Canopy Growth Corp(CGC)的股票是買入、持有還是賣出？
根據分析師評級，Canopy Growth Corp(CGC)的總體評級為signal_hold，目標價格為1.22。
Canopy Growth Corp(CGC)股票的每股收益（EPS TTM）是多少
Canopy Growth Corp(CGC)股票的每股收益（EPS TTM）是-0.63。
